Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/07/2010WO2010086828A3 Agonist anti-trkb monoclonal antibodies
10/07/2010WO2010078833A8 Modified sodium-montmorillonite, preparing method and uses thereof
10/07/2010WO2010065709A3 Hydroxamic acid derivatives, preparation and therapeutic uses thereof
10/07/2010WO2010063470A9 Methods for preventing or reducing colon carcinogenesis
10/07/2010WO2010062136A3 Composition for mitochondrial activation
10/07/2010WO2010043866A3 Histone lysine demethylase inhibitors
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100257616 DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof
10/07/2010US20100256243 Dosing Regimen for the Treatment of Alzheimer's Disease With Sulfonyl Fluorides
10/07/2010US20100256241 Method for treating atypical facial pain
10/07/2010US20100256229 Compositions of cholinesterase inhibitors
10/07/2010US20100256221 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/07/2010US20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256208 Novel process
10/07/2010US20100256202 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/07/2010US20100256194 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
10/07/2010US20100256193 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
10/07/2010US20100256192 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
10/07/2010US20100256191 Ampa receptor antagonists and zonisamide for epilepsy
10/07/2010US20100256190 Small-volume oral transmucosal dosage forms
10/07/2010US20100256187 Composition of 2,4,6- trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010US20100256186 Sulfonyl-piperidin-4-yl methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/07/2010US20100256182 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
10/07/2010US20100256179 Combination therapy for pain in painful diabetic neuropathy
10/07/2010US20100256175 Treatment for drug addiction
10/07/2010US20100256173 Method of Treating Cognitive Impairment
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256163 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
10/07/2010US20100256162 Piperazine and Piperidine Derivatives
10/07/2010US20100256159 Stable liquid pharmaceutical composition based on trazodone
10/07/2010US20100256154 Isoxazolo-pyrazine derivatives
10/07/2010US20100256152 Novel pharmaceutical composition for treatment of schizophrenia
10/07/2010US20100256151 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
10/07/2010US20100256150 Cyclic hydroxylamine as psychoactive compounds
10/07/2010US20100256145 Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256135 Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
10/07/2010US20100256133 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
10/07/2010US20100256132 Il-12 modulatory compounds
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256129 Selective androgen receptor modulators (sarms) and uses thereof
10/07/2010US20100256128 Gamma secretase modulators
10/07/2010US20100256127 Substituted isoxazoles
10/07/2010US20100256122 Butyl and butynyl benzyl amine compounds
10/07/2010US20100256121 Substituted diazepan orexin receptor antagonists
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256116 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
10/07/2010US20100256111 Therapeutic agents useful for treating pain
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100256091 Pharmaceutical powder compositions
10/07/2010US20100256085 Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses
10/07/2010US20100256075 High Yield Secretion of Multimeric Recombinant Protein
10/07/2010US20100256066 Active soluble post-translationally modified neuregulin isoforms
10/07/2010US20100256065 Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
10/07/2010US20100256056 Analogues of exendin-4 and exendin-3
10/07/2010US20100256055 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255123 Skin moisturizer, blood circulation promoter, and external preparations for the skin containing the skin moisturizer and the blood circulation promoter
10/07/2010US20100255113 Herbal composition for treatment of neurodegeneration and neuronal dysfunction
10/07/2010US20100255110 Functional agricultural product and method for cultivating the same
10/07/2010US20100255102 Sterilization of dispersions of nanoparticulate active agents with gamma radiation
10/07/2010US20100255099 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
10/07/2010US20100255094 Bupropion hydrobromide and therapeutic applications
10/07/2010US20100255093 Sustained release oral dosage forms of an r-baclofen prodrug
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255073 Composition for transdermal delivery of fentanyl
10/07/2010US20100255067 Controlled Release Pharmaceutical Compositions of Pregabalin
10/07/2010US20100255066 Orally-administered agent
10/07/2010US20100255064 Compressed Chewing Gum Tablet
10/07/2010US20100255063 Compressed Chewing Gum Tablet
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254980 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254953 Cell growth method and pharmaceutical preparation for tissue repair and regeneration
10/07/2010US20100254951 Nerve Regeneration Promoting Agent
10/07/2010CA2759187A1 Compositions for treatment of alzheimer's disease
10/07/2010CA2757726A1 Acrylamide compounds and the use thereof
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757419A1 Plant fiber product and method for its manufacture
10/07/2010CA2757311A1 Antipsychotic agents and standardized antipsychotic fractions from rauwolfia tetraphylla and process of their isolation
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2757144A1 Low dose pipamperone in treating mood disorders
10/07/2010CA2757019A1 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2756877A1 Orally disintegrating coated tablet
10/07/2010CA2756873A1 Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
10/07/2010CA2749218A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
1 ... 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 ... 1833